1
Ronald James Jandacek: Compositions for treating hypercholesterolemia. The Procter & Gamble Company, Richard C Witte, Julius P Filcik, Jerry J Yetter, January 25, 1977: US04005195 (175 worldwide citation)

Anti-anal leakage agents are used in combination with liquid polyol fatty acid polyesters to provide pharmaceutical and food compositions for treating and/or preventing hypercholesterolemia while avoiding undesired anal leakage of the liquid polyesters.


2
Ronald James Jandacek, Fred Hugh Mattson: Vitaminized compositions for treating hypercholesterolemia. The Procter & Gamble Company, Richard C Witte, Julius P Filcik, Jerry J Yetter, January 25, 1977: US04005196 (154 worldwide citation)

Anti-anal leakage agents are used in combination with vitamin-fortified liquid fatty acid polyester compositions to provide pharmaceutical and food compositions for treating and/or preventing hypercholesterolemia while avoiding undesired anal leakage of the polyesters.


3
Ronald James Jandacek, Gary Robert Kelm, Satinder Singh Bharaj, Jorge Villanueva Penafiel: Compositions and methods for body weight management. The Procter & Gamble Company, Kelly L McDow Dunham, Cynthia L Clay, April 11, 2006: US07025984 (7 worldwide citation)

The present invention is for compositions and methods for managing the body weight of a subject using said compositions. Weight management, particularly weight gain and loss, is effectuated by producing a sensation of satiety in said subjects. The method of managing body weight includes administerin ...


4
Ronald James Jandacek, Gary Robert Kelm, Satinder Singh Bharaj, Jorge Villanueva Penafiel: Compositions and methods for body weight management. The Procter & Gamble Company, Amy M Foust, Kelly L McDow, Adam W Borgman, October 16, 2012: US08287898 (5 worldwide citation)

The present invention is for compositions and methods for managing the body weight of a subject using said compositions. Weight management, particularly weight gain and loss, is effectuated by producing a sensation of satiety in said subjects. The method of managing body weight includes administerin ...


5
Ronald James Jandacek, William Randall Francis, Gary Robert Kelm, Bryn Hird: Compositions, methods, and kits useful for the alleviation of gastrointestinal effects. The Procter & Gamble Company, Alexandra S Anoff, February 12, 2013: US08372430

Disclosed are compositions, methods, and kits for treating conditions including; ameliorating side effects associated with compounds such as lipase inhibitors; gastrointestinal distress; fecal urgency; obesity; hyperlipidemia; diarrhea; reducing levels of toxic substances; reducing blood cholesterol ...


6
Ronald James Jandacek, Patrick Tso, James E Heubi: Use of non-absorbable fat in determining dietary fat absorption. Children s Hospital Medical Center, University of Cincinnati, Hasse & Nesbitt, Daniel F Nesbitt, April 13, 2010: US07695971

The use of sucrose polyester containing behenate fatty acid chains as a non-absorbable fat marker to determine total dietary fat absorption by the digestive tract of a subject. A test food for use in measuring fat absorption contains a non-absorbable fat and a dietary fat. The method is useful for d ...


7

8

9
Ronald James Jandacek, William Randall Francis, Gary Robert Kelm, Bryn Hird: Compositions, methods, and kits useful for the alleviation of gastrointestinal effects. The Procter & Gamble Company, July 1, 2004: US20040126424-A1

This disclosure relates to compositions suitable for a variety of treatments, including ameliorating the undesirable side effects associated with compounds such as lipase inhibitors (e.g., anal leakage of undigested fat or oil). In particular, one embodiment of the present invention relates to compo ...


10
Bryn Hird, Ronald James Jandacek: Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by the body. The Procter & Gamble Company, The Procter & Gamble Company, May 13, 2004: US20040091450-A1

This disclosure relates to compositions comprising an open-celled polymeric foam wherein the compositions are useful for sequestering lipophilic materials present in the gastrointestinal tract, thereby inhibiting the absorption of such lipophilic materials by the body. The disclosure further relates ...